Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida,
Latin Name:
Numida meleagris
Tested tissues: PBMC,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0061 | 2021.04 | iDrop | PBMC | Normal | 495 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
Human gammaherpesvirus 4 | ||
Human metapneumovirus |
PBMC-Platelets : 78.95% ; PBMC-Neutrophil : 56.94% ; PBMC-T cells : 44.23% ; |
|
Simian rotavirus A strain RRV |
PBMC-Platelets : 78.95% ; PBMC-Neutrophil : 56.94% ; PBMC-T cells : 44.23% ; PBMC-Platelets : 52.63% ; PBMC-Neutrophil : 7.41% ; PBMC-T cells : 3.08% ; PBMC-Platelets : 47.37% ; PBMC-Neutrophil : 7.87% ; PBMC-T cells : 1.54% ; PBMC-Neutrophil : 34.72% ; PBMC-T cells : 28.08% ; PBMC-Platelets : 5.26% ; PBMC-Platelets : 31.58% ; PBMC-Neutrophil : 21.30% ; PBMC-T cells : 8.46% ; |
|
Mammalian orthoreovirus |
PBMC-Platelets : 78.95% ; PBMC-Neutrophil : 56.94% ; PBMC-T cells : 44.23% ; |
|
Human betaherpesvirus 5 | ||
Human rotavirus strain WA | ||
Human parvovirus B19 |
PBMC-Platelets : 78.95% ; PBMC-Neutrophil : 56.94% ; PBMC-T cells : 44.23% ; |
|
Echovirus E8 | ||
Foot-and-mouth disease virus | ||
Adeno-associated virus - 2 | ||
Equid alphaherpesvirus 1 | ||
Echovirus E1 | ||
Adeno-associated virus 9 |
PBMC-T cells : 61.54% ; PBMC-Neutrophil : 58.80% ; PBMC-Platelets : 21.05% ; |
|
Adeno-associated virus - 3 |
PBMC-T cells : 61.54% ; PBMC-Neutrophil : 58.80% ; PBMC-Platelets : 21.05% ; |
|
Sindbis virus |
PBMC-T cells : 61.54% ; PBMC-Neutrophil : 58.80% ; PBMC-Platelets : 21.05% ; |
|
Adeno-associated virus - 8 |
PBMC-T cells : 61.54% ; PBMC-Neutrophil : 58.80% ; PBMC-Platelets : 21.05% ; |
|
Dengue virus | ||
Venezuelan equine encephalitis virus |
PBMC-T cells : 61.54% ; PBMC-Neutrophil : 58.80% ; PBMC-Platelets : 21.05% ; |
|
Classical swine fever virus | ||
Hantaan orthohantavirus |
PBMC-Platelets : 47.37% ; PBMC-Neutrophil : 7.87% ; PBMC-T cells : 1.54% ; |
|
Coxsackievirus A9 | ||
Human parechovirus 1 | ||
West Nile virus | ||
Human gammaherpesvirus 8 | ||
Bovine leukemia virus |
PBMC-Neutrophil : 45.83% ; PBMC-T cells : 38.46% ; PBMC-Platelets : 10.53% ; |
|
Feline immunodeficiency virus | ||
Human immunodeficiency virus 2 | ||
Human immunodeficiency virus 1 | ||
Severe acute respiratory syndrome coronavirus 2 |
PBMC-Platelets : 42.11% ; PBMC-Neutrophil : 3.24% ; PBMC-T cells : 1.54% ; |
|
Hepacivirus C | ||
Coxsackievirus B1 | ||
Human alphaherpesvirus 1 |
PBMC-Platelets : 31.58% ; PBMC-Neutrophil : 21.30% ; PBMC-T cells : 8.46% ; |
|
Human mastadenovirus C | ||
Lassa mammarenavirus | ||
Human papillomavirus type 16 |
PBMC-Platelets : 15.79% ; PBMC-Neutrophil : 2.31% ; PBMC-T cells : 0.77% ; |
|
Influenza A virus | ||
Machupo mammarenavirus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Feline panleukopenia virus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Mouse mammary tumor virus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Canine parvovirus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Argentinian mammarenavirus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Guanarito mammarenavirus |
PBMC-Neutrophil : 13.89% ; PBMC-Platelets : 5.26% ; PBMC-T cells : 2.69% ; |
|
Human betaherpesvirus 6 |
PBMC-T cells : 10.00% ; PBMC-Neutrophil : 9.26% ; PBMC-Platelets : 5.26% ; |
|
Bovine viral diarrhea virus 1 |
PBMC-T cells : 10.00% ; PBMC-Neutrophil : 9.26% ; PBMC-Platelets : 5.26% ; |
|
Human mastadenovirus B |
PBMC-T cells : 10.00% ; PBMC-Neutrophil : 9.26% ; PBMC-Platelets : 5.26% ; |
|
Measles morbillivirus | ||
Human mastadenovirus D | ||
Human betaherpesvirus 6A |
PBMC-T cells : 10.00% ; PBMC-Neutrophil : 9.26% ; PBMC-Platelets : 5.26% ; |
|
Ebola virus | ||
Rinderpest morbillivirus |
PBMC-Neutrophil : 6.94% ; PBMC-T cells : 5.38% ; PBMC-Platelets : 0.00% ; |
|
Phocine morbillivirus |
PBMC-Neutrophil : 6.94% ; PBMC-T cells : 5.38% ; PBMC-Platelets : 0.00% ; |
|
Middle East respiratory syndrome-related coronavirus |
PBMC-Neutrophil : 6.94% ; PBMC-T cells : 1.15% ; PBMC-Platelets : 0.00% ; |
|
Canine morbillivirus |
PBMC-Neutrophil : 6.94% ; PBMC-T cells : 5.38% ; PBMC-Platelets : 0.00% ; |
|
Human alphaherpesvirus 3 |
PBMC-Neutrophil : 5.56% ; PBMC-T cells : 1.92% ; PBMC-Platelets : 0.00% ; |
|
Varicella Zoster Virus |
PBMC-Neutrophil : 5.56% ; PBMC-T cells : 1.92% ; PBMC-Platelets : 0.00% ; |
|
Simian immunodeficiency virus |
PBMC-T cells : 5.38% ; PBMC-Neutrophil : 1.85% ; PBMC-Platelets : 0.00% ; |
|
Human betaherpesvirus 7 |
PBMC-T cells : 5.38% ; PBMC-Neutrophil : 1.85% ; PBMC-Platelets : 0.00% ; |
|
JC polyomavirus |
PBMC-Platelets : 5.26% ; PBMC-Neutrophil : 0.93% ; PBMC-T cells : 0.77% ; |
|
Enterovirus A71 | ||
Vesicular stomatitis virus |
PBMC-Neutrophil : 3.70% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Feline leukemia virus strain C/FA27 |
PBMC-Neutrophil : 3.24% ; PBMC-T cells : 2.69% ; PBMC-Platelets : 0.00% ; |
|
Xenotropic murine leukemia virus |
PBMC-Neutrophil : 2.78% ; PBMC-T cells : 1.54% ; PBMC-Platelets : 0.00% ; |
|
Polytropic murine leukemia virus |
PBMC-Neutrophil : 2.78% ; PBMC-T cells : 1.54% ; PBMC-Platelets : 0.00% ; |
|
Human betaherpesvirus 6B |
PBMC-T cells : 2.69% ; PBMC-Neutrophil : 0.93% ; PBMC-Platelets : 0.00% ; |
|
Simian sarcoma-associated virus |
PBMC-Neutrophil : 2.31% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.00% ; |
|
Gibbon ape leukemia virus | ||
Feline leukemia virus strain B/lambda-B1 | ||
Respiratory syncytial virus |
PBMC-T cells : 2.31% ; PBMC-Neutrophil : 0.93% ; PBMC-Platelets : 0.00% ; |
|
Amphotropic murine leukemia virus |
PBMC-T cells : 1.92% ; PBMC-Neutrophil : 0.93% ; PBMC-Platelets : 0.00% ; |
|
Jaagsiekte sheep retrovirus |
PBMC-Neutrophil : 1.85% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.00% ; |
|
Human mastadenovirus F |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B6 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B4 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus A16 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B2 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Human mastadenovirus A |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B5 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Human mastadenovirus E |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B3 |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Chikungunya virus |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Rabies lyssavirus |
PBMC-Neutrophil : 1.39% ; PBMC-T cells : 0.38% ; PBMC-Platelets : 0.00% ; |
|
Oliveros mammarenavirus |
PBMC-T cells : 1.15% ; PBMC-Neutrophil : 0.46% ; PBMC-Platelets : 0.00% ; |
|
Lymphocytic choriomeningitis mammarenavirus | ||
Latino mammarenavirus |
PBMC-T cells : 1.15% ; PBMC-Neutrophil : 0.46% ; PBMC-Platelets : 0.00% ; |
|
Hendra henipavirus |
PBMC-Neutrophil : 0.93% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Nipah henipavirus |
PBMC-Neutrophil : 0.93% ; PBMC-T cells : 0.77% ; PBMC-Platelets : 0.00% ; |
|
Zika virus |
PBMC-T cells : 0.77% ; PBMC-Neutrophil : 0.46% ; PBMC-Platelets : 0.00% ; |
|
Marburg marburgvirus |
PBMC-T cells : 0.77% ; PBMC-Neutrophil : 0.46% ; PBMC-Platelets : 0.00% ; |